









Markets
/
Stocks
/
nasdaq-bway
/

Brainsway Ltd

BWAY

21.780USD

+0.850+4.06%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

413.90MMarket Cap

66.07P/E TTM



Brainsway Ltd

21.780

+0.850+4.06%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Brainsway Ltd

Currency: USD Updated: 2026-02-06

Key Insights

Brainsway Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 87 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 30.00.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Brainsway Ltd's Score

Industry at a Glance

Industry Ranking

87 / 205

Overall Ranking

236 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Brainsway Ltd Highlights

StrengthsRisks

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 50.92% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 41.02M.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Fairly Valued

The company’s latest PE is 66.07, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 6.12M shares, increasing 8.58% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 313.16K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of -0.10.

Analyst Rating

Based on 2 analysts

Buy

Current Rating

30.000

Target Price

+35.47%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Brainsway Ltd is 8.85, ranking 29 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 13.51M, representing a year-over-year increase of 28.66%, while its net profit experienced a year-over-year increase of 136.56%.

Score

Industry at a Glance

Previous score

8.85

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.94

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.02

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.74

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.57

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Brainsway Ltd's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Brainsway Ltd is 4.12, ranking 195 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 66.07, which is 613.27% below the recent high of 471.25 and 316.58% above the recent low of -143.09.

Score

Industry at a Glance

Previous score

4.12

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 87/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Brainsway Ltd is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 23.50, with a high of 24.00 and a low of 23.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts

Buy

Current Rating

30.000

Target Price

+35.47%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Brainsway Ltd

BWAY

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Brainsway Ltd is 7.19, ranking 45 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 24.84 and the support level at 19.53, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.90

Change

0.29

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-1.025

Neutral

RSI(14)

47.855

Neutral

STOCH(KDJ)(9,3,3)

22.313

Neutral

ATR(14)

1.559

High Vlolatility

CCI(14)

-121.021

Sell

Williams %R

72.881

Sell

TRIX(12,20)

0.537

Sell

StochRSI(14)

38.712

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

22.207

Sell

MA10

23.350

Sell

MA20

23.350

Sell

MA50

20.287

Buy

MA100

18.006

Buy

MA200

14.997

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Brainsway Ltd is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 32.49%, representing a quarter-over-quarter decrease of 2.95%. The largest institutional shareholder is James Simons, holding a total of 313.16K shares, representing 1.60% of shares outstanding, with 1.11% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Valor Equity Partners

2.66M

+26.32%

Masters Capital Management, L.L.C.

1.00M

Phoenix Financial Ltd

697.26K

+190.09%

Acadian Asset Management LLC

394.56K

+18.04%

Renaissance Technologies LLC

Star Investors

313.16K

+10.32%

Essex Investment Management Company, LLC

310.68K

+3.24%

Shulkin (Jonathan K.)

268.25K

Gracias (Antonio J)

243.50K

Two Sigma Investments, LP

193.80K

+12.29%

Cresset Asset Management, LLC

157.46K

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Brainsway Ltd is 3.95, ranking 116 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.21. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.